Transthyretin Amyloidosis Clinical Trial
Official title:
A Comprehensive Retrospective Study of Cerebral MRI Anomalies in Mutated Transthyretin Amyloidosis Patients
Transthyretin amyloidosis (aTTR) initially described as a rare disease, became the most serious hereditary polyneuropathy of adult onset and family screening has made it possible to identify and follow up many asymptomatic patients and carriers of the mutation in the TTR gene. Considered as a systemic disease with involvement of target organs (the heart, the eye, the kidney and peripheral nervous system), it seems to be more complex for neurologists according to recent publications raising the issue of central nervous system involvement. Indeed, TTR amyloid deposits seem to be correlated with the duration of the disease. These deposits can cause cortical damage by different mechanisms: direct TTR toxicity or as a result of pathology related to cerebral amyloid angiopathy (intraparenchymal or subarachnoid hematomas, small infarcts, hemosiderin). A small number of mutations in the TTR gene cause a rare phenotype of systemic amyloidosis, the oculoleptomeningeal form, characterized by clinical neurological symptoms: progressive dementia, epilepsy, ataxia, spastic paraparesis, stroke-like episodes. Hypothesis of the work: the central nervous system involvement is probably underestimated on the radiological description in patients with TTR mutation.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03190577 -
Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology
|
N/A | |
| Completed |
NCT03588468 -
Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study
|
N/A | |
| Completed |
NCT03591757 -
Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)
|
Early Phase 1 | |
| Recruiting |
NCT05577819 -
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
|
N/A | |
| Terminated |
NCT04611204 -
Transthyretin Cardiac Amyloidosis in Patients With Idiopathic Carpal Tunnel Syndrome Referred for Release Surgery
|
||
| Recruiting |
NCT03352089 -
Positron Emission Tomography / Magnetic Resonance Imaging in Aortic Stenosis
|
N/A | |
| Recruiting |
NCT05814380 -
The Regional Scintigraphic DPD Uptake in Cardiac Transthyretin Amyloidosis.
|
||
| Completed |
NCT03886155 -
Cardiac Amyloidosis Screening at Trigger Finger Release
|
||
| Completed |
NCT03923920 -
Screening for Systemic Amyloidosis Via the Ligamentum Flavum
|
||
| Completed |
NCT03862807 -
Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant
|
Phase 3 | |
| Completed |
NCT02792790 -
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
|
||
| Completed |
NCT03860935 -
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
|
Phase 3 | |
| Recruiting |
NCT04963985 -
The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients
|
Phase 4 | |
| Recruiting |
NCT05409833 -
Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population
|
||
| Recruiting |
NCT05635045 -
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
|
Phase 2 | |
| Completed |
NCT01171859 -
Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin Amyloidosis
|
Phase 2 | |
| Recruiting |
NCT03237494 -
TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects
|
||
| Recruiting |
NCT04899180 -
Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
|
Early Phase 1 | |
| Recruiting |
NCT06345235 -
New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis
|
||
| Completed |
NCT00628745 -
Transthyretin Amyloidosis Outcome Survey (THAOS)
|